Pilot open label study with alprazolam (U31, 889) in outpatients with neurotic depression.
D000275:Adjustment Disorders / Q000188:drug therapy*; D000328:Adult; D014151:Anti-Anxiety Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001569:Benzodiazepines; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008609:Mental Status Schedule; D008875:Middle Aged; D014230:Triazoles / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use
D014151:Anti-Anxiety Agents; D014230:Triazoles; D001569:Benzodiazepines